1

ABBV-744 as a potential therapeutic option for aggressive cancers Secrets

News Discuss 
Participant eaten grapefruit or grapefruit merchandise within 3 times prior to the 1st dose of study drug. - "Our study disclosed the vital role on the KLF16/MYC regulatory axis in modulating tumor expansion and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, like OTX015 or ABBV-744, with DDP or https://hilairem776zku9.mycoolwiki.com/user

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story